REDX — Redx Pharma Share News
0.000.00%
- £35.01m
- £34.60m
- £4.20m
Holdings in Company
TR-1: Notification of major holdings
TR-1: Notification of major holdings
Brief: Redx Pharma Unveils Preclinical Data From Rxc009
Redx Unveils Preclinical Data from RXC009
Redx to present preclinical data on RXC009 at ASN
Proposed Subscription to raise c.£14.1 million
Confirmation of Directorate Change
Directorate Change
Brief: Redx Pharma Says Zelasudil Granted FDA Orphan Drug Designation
Zelasudil granted FDA Orphan Drug Designation
Directorate Change
New Grant of Options
Redx to present at Jefferies Healthcare Conference
UK Stocks-Factors to watch on May 17 (updated)
Brief: Redx Pharma Says Cash Balance At 31 March Of £34.6 Mln
Interim Results for the Six Months Ended 31 March
UK Stocks-Factors to watch on May 17
Discovery of Pirtobrutinib Recognised with Plaque